<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Benefit of PEG-rHuMGDF in myelosuppressed mice</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Benefit of PEG-rHuMGDF in myelosuppressed mice</h1>
<div class="graphic"><div class="figure"><div class="ttl">Benefit of PEG-rHuMGDF in myelosuppressed mice</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Effect of PEG-rHuMGDF (red lines) or placebo (blue lines) on the platelet, white blood cell (WBC), and red blood cell (RBC) counts in mice treated with a combination of carboplatin and sublethal irradiation. Mice treated with PEG-rHuMGDF had accelerated recovery of all blood cell lineages and reduced mortality (15 versus 94 percent).</div><div class="graphic_reference">Data from Hokom, MM, Lacey, D, Kinstler, OB, et al, Blood 1995; 86:4486.</div><div id="graphicVersion">Graphic 82447 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
